Reflect Scientific, Inc. (RSCF)
OTCMKTS: RSCF · Delayed Price · USD
0.0525
0.00 (0.00%)
Jul 1, 2024, 10:48 AM EDT - Market closed
Reflect Scientific Revenue
Reflect Scientific had revenue of $1.27M in the twelve months ending March 31, 2024, down -17.08% year-over-year. Revenue in the quarter ending March 31, 2024 was $428.76K with 77.81% year-over-year growth. In the year 2023, Reflect Scientific had annual revenue of $1.08M, a decrease of -47.08%.
Revenue (ttm)
$1.27M
Revenue Growth
-17.08%
P/S Ratio
3.55
Revenue / Employee
$181,112
Employees
7
Market Cap
4.50M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.08M | -961.14K | -47.08% |
Dec 31, 2022 | 2.04M | -773.37K | -27.48% |
Dec 31, 2021 | 2.81M | 22.05K | 0.79% |
Dec 31, 2020 | 2.79M | 1.18M | 73.54% |
Dec 31, 2019 | 1.61M | 57.26K | 3.69% |
Dec 31, 2018 | 1.55M | 486.21K | 45.62% |
Dec 31, 2017 | 1.07M | -122.83K | -10.33% |
Dec 31, 2016 | 1.19M | 151.29K | 14.58% |
Dec 31, 2015 | 1.04M | -490.60K | -32.11% |
Dec 31, 2014 | 1.53M | 240.90K | 18.72% |
Dec 31, 2013 | 1.29M | -42.03K | -3.16% |
Dec 31, 2012 | 1.33M | -658.29K | -33.12% |
Dec 31, 2011 | 1.99M | -414.35K | -17.25% |
Dec 31, 2010 | 2.40M | -3.26M | -57.55% |
Dec 31, 2009 | 5.66M | -4.47M | -44.13% |
Dec 31, 2008 | 10.13M | 2.11M | 26.27% |
Dec 31, 2007 | 8.02M | 5.45M | 211.71% |
Dec 31, 2006 | 2.57M | 331.89K | 14.81% |
Dec 31, 2005 | 2.24M | 137.73K | 6.55% |
Dec 31, 2004 | 2.10M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 379.49B |
Johnson & Johnson | 81.80B |
Merck & Co. | 61.40B |
AbbVie | 54.40B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Abbott Laboratories | 40.33B |
RSCF News
- 2 months ago - Reflect Scientific Inc. Announces Second Quarter Sale of Groundbreaking Aerospace Manufacturing Solution - GlobeNewsWire
- 9 months ago - Reflect Scientific Inc. Announces Successful Testing of Liquid Nitrogen Temperature Control Technology - GlobeNewsWire
- 10 months ago - Reflect Scientific Inc. Announces Record-Breaking Freezer Order from a $40B BioPharma Company - GlobeNewsWire
- 11 months ago - Reflect Scientific Secures $200,000 Order from Prominent Bio-Pharma Client for Blast Freezers - GlobeNewsWire
- 1 year ago - Reflect Scientific Inc Receives Order for B-90 Plasma Freezer, Continues to Expand Clientele - GlobeNewsWire
- 1 year ago - Reflect Scientific Inc Reports First Quarter 2023 Results - GlobeNewsWire
- 1 year ago - Reflect Scientific Inc Announces Year-End Financial Results for 2022 - GlobeNewsWire
- 1 year ago - Reflect Scientific Inc. Releases Third Quarter 2022 Financials - GlobeNewsWire